Skip to main content
SpringerLink
Log in

Invasion and metastasis—recent advances and future challenges

  • Meeting Report
  • Published:
Journal of Molecular Medicine Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

Each participant was asked to supply up to three references to their own work, as background.

  1. Plaks V, Koopman CD, Werb Z (2013) Cancer. Circulating tumor cells. Science 341(6151):1186–1188

    Article  CAS  PubMed  Google Scholar 

  2. Chou J, Lin JH, Brenot A, Kim JW, Provot S, Werb Z (2013) GATA3 suppresses metastasis and modulates the tumour microenvironment by regulating microRNA-29b expression. Nat Cell Biol 15(2):201–213

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  3. Casbon AJ, Reynaud D, Park C, Khuc E, Gan DD, Schepers K, Passegue E, Werb Z (2015) Invasive breast cancer reprograms early myeloid differentiation in the bone marrow to generate immunosuppressive neutrophils. Proc Natl Acad U S A 112(6):E566–75.

  4. Wan L, Pantel K, Kang Y (2013) Tumor metastasis: moving new biological insights into the clinic. Nat Med 19(11):1450–1464

    Article  CAS  PubMed  Google Scholar 

  5. Wan L, Lu X, Yuan S, Wei Y, Guo F, Shen M, Yuan M, Chakrabarti R, Hua Y, Smith HA et al (2014) MTDH-SND1 interaction is crucial for expansion and activity of tumor-initiating cells in diverse oncogene- and carcinogen-induced mammary tumors. Cancer Cell 26(1):92–105

    Article  CAS  PubMed  Google Scholar 

  6. Aceto N, Bardia A, Miyamoto DT, Donaldson MC, Wittner BS, Spencer JA, Yu M, Pely A, Engstrom A, Zhu H et al (2014) Circulating tumor cell clusters are oligoclonal precursors of breast cancer metastasis. Cell 158(5):1110–1122

    Article  CAS  PubMed  Google Scholar 

  7. Iacobuzio-Donahue CA, Fu B, Yachida S, Luo M, Abe H, Henderson CM, Vilardell F, Wang Z, Keller JW, Banerjee P et al (2009) DPC4 gene status of the primary carcinoma correlates with patterns of failure in patients with pancreatic cancer. J Clin Oncol 27(11):1806–1813

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  8. Yachida S, White CM, Naito Y, Zhong Y, Brosnan JA, Macgregor-Das AM, Morgan RA, Saunders T, Laheru DA, Herman JM et al (2012) Clinical significance of the genetic landscape of pancreatic cancer and implications for identification of potential long-term survivors. Clin Cancer Res 18(22):6339–6347

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  9. Yachida S, Jones S, Bozic I, Antal T, Leary R, Fu B, Kamiyama M, Hruban RH, Eshleman JR, Nowak MA et al (2010) Distant metastasis occurs late during the genetic evolution of pancreatic cancer. Nature 467(7319):1114–1117

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  10. Irwin MS, Park JR (2015) Neuroblastoma: paradigm for precision medicine. Pediatr Clin N Am 62(1):225–256

    Article  Google Scholar 

  11. Schwartzentruber J, Korshunov A, Liu XY, Jones DT, Pfaff E, Jacob K, Sturm D, Fontebasso AM, Quang DA, Tonjes M et al (2012) Driver mutations in histone H3.3 and chromatin remodelling genes in paediatric glioblastoma. Nature 482(7384):226–231

    Article  CAS  PubMed  Google Scholar 

  12. Fontebasso AM, Gayden T, Nikbakht H, Neirinck M, Papillon-Cavanagh S, Majewski J, Jabado N (2014) Epigenetic dysregulation: a novel pathway of oncogenesis in pediatric brain tumors. Acta Neuropathol 128(5):615–627

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  13. Sturm D, Bender S, Jones DT, Lichter P, Grill J, Becher O, Hawkins C, Majewski J, Jones C, Costello JF et al (2014) Paediatric and adult glioblastoma: multiform (epi)genomic culprits emerge. Nat Rev Cancer 14(2):92–107

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  14. Samanta D, Gilkes DM, Chaturvedi P, Xiang L, Semenza GL (2014) Hypoxia-inducible factors are required for chemotherapy resistance of breast cancer stem cells. Proc Natl Acad Sci U S A 111(50):E5429–5438

    Article  CAS  PubMed  Google Scholar 

  15. Tozluoglu M, Tournier AL, Jenkins RP, Hooper S, Bates PA, Sahai E (2013) Matrix geometry determines optimal cancer cell migration strategy and modulates response to interventions. Nat Cell Biol 15(7):751–762

    Article  CAS  PubMed  Google Scholar 

  16. Madsen CD, Hooper S, Tozluoglu M, Bruckbauer A, Fletcher G, Erler JT, Bates PA, Thompson B, Sahai E (2015) STRIPAK components determine mode of cancer cell migration and metastasis. Nat Cell Biol 17(1):68–80

    Article  CAS  PubMed  Google Scholar 

  17. Braun S, Vogl FD, Naume B, Janni W, Osborne MP, Coombes RC, Schlimok G, Diel IJ, Gerber B, Gebauer G et al (2005) A pooled analysis of bone marrow micrometastasis in breast cancer. N Engl J Med 353(8):793–802

    Article  CAS  PubMed  Google Scholar 

  18. Alix-Panabieres C, Pantel K (2014) Challenges in circulating tumour cell research. Nat Rev Cancer 14(9):623–631

    Article  CAS  PubMed  Google Scholar 

  19. Schwarzenbach H, Nishida N, Calin GA, Pantel K (2014) Clinical relevance of circulating cell-free microRNAs in cancer. Nat Rev Clin Oncol 11(3):145–156

    Article  CAS  PubMed  Google Scholar 

  20. Goss PE, Chambers AF (2010) Does tumour dormancy offer a therapeutic target? Nat Rev Cancer 10(12):871–877

    Article  CAS  PubMed  Google Scholar 

  21. Murrell DH, Foster PJ, Chambers AF (2014) Brain metastases from breast cancer: lessons from experimental magnetic resonance imaging studies and clinical implications. J Mol Med (Berl) 92(1):5–12

    Article  Google Scholar 

  22. Barkan D, Green JE, Chambers AF (2010) Extracellular matrix: a gatekeeper in the transition from dormancy to metastatic growth. Eur J Cancer 46(7):1181–1188

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  23. Steeg PS (2012) Perspective: the right trials. Nature 485(7400):S58–59

    Article  CAS  PubMed  Google Scholar 

  24. Zimmer AS, Steeg PS (2015) Meaningful prevention of breast cancer metastasis: candidate therapeutics, preclinical validation, and clinical trial concerns. J Mol Med (Berl) 93(1):13–29

    Article  CAS  Google Scholar 

  25. Williams KC, McNeilly RE, Coppolino MG (2014) SNAP23, Syntaxin4, and vesicle-associated membrane protein 7 (VAMP7) mediate trafficking of membrane type 1-matrix metalloproteinase (MT1-MMP) during invadopodium formation and tumor cell invasion. Mol Biol Cell 25(13):2061–2070

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  26. Williams KC, Coppolino MG (2014) SNARE-dependent interaction of Src, EGFR and beta1 integrin regulates invadopodia formation and tumor cell invasion. J Cell Sci 127(Pt 8):1712–1725

    Article  CAS  PubMed  Google Scholar 

  27. Kaplan RN, Riba RD, Zacharoulis S, Bramley AH, Vincent L, Costa C, MacDonald DD, Jin DK, Shido K, Kerns SA et al (2005) VEGFR1-positive haematopoietic bone marrow progenitors initiate the pre-metastatic niche. Nature 438(7069):820–827

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  28. Zhang H, Maric I, DiPrima MJ, Khan J, Orentas RJ, Kaplan RN, Mackall CL (2013) Fibrocytes represent a novel MDSC subset circulating in patients with metastatic cancer. Blood 122(7):1105–1113

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  29. Highfill SL, Cui Y, Giles AJ, Smith JP, Zhang H, Morse E, Kaplan RN, Mackall CL. (2014) Disruption of CXCR2-mediated MDSC tumor trafficking enhances anti-PD1 efficacy. Sci Transl Med. 6(237):237ra67. doi:10.1126/scitranslmed.3007974

  30. Shields MA, Dangi-Garimella S, Redig AJ, Munshi HG (2012) Biochemical role of the collagen-rich tumour microenvironment in pancreatic cancer progression. Biochem J 441(2):541–552

    Article  CAS  PubMed  Google Scholar 

  31. Guerrero JA, Bennett C, van der Weyden L, McKinney H, Chin M, Nurden P, McIntyre Z, Cambridge EL, Estabel J, Wardle-Jones H et al (2014) Gray platelet syndrome: proinflammatory megakaryocytes and alpha-granule loss cause myelofibrosis and confer metastasis resistance in mice. Blood 124(24):3624–3635

    Article  CAS  PubMed  Google Scholar 

Download references

Authorship statement

Ann F. Chambers and Zena Werb jointly wrote this manuscript. The work described has not been published before; it is not under consideration for publication anywhere else; and both authors approve its publication. All participants mentioned in this meeting report have seen and approved the section that describes their presentation and the submission of this work. Officials of the William Guy Forbeck Research Foundation also have seen and approved the submission of this manuscript.

Author information

Authors and Affiliations

  1. London Regional Cancer Program, 790 Commissioners Road East, London, Ontario, N6A 4L6, Canada

    Ann F. Chambers

  2. Department of Anatomy, University of California, Box 0452, HSW 1323, 513 Parnassus Avenue, San Francisco, CA, 94143-0452, USA

    Zena Werb

Authors
  1. Ann F. Chambers
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Zena Werb
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Ann F. Chambers.

Additional information

WILLIAM GUY FORBECK RESEARCH FOUNDATION 2014 Forum on Invasion and Metastasis, November 6–9, 2014, Hilton Head, SC

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Chambers, A.F., Werb, Z. Invasion and metastasis—recent advances and future challenges. J Mol Med 93, 361–368 (2015). https://doi.org/10.1007/s00109-015-1269-z

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00109-015-1269-z

Keywords

Search

Navigation